BRIEF published on 10/28/2025 at 08:10, 5 months 17 days ago BioCina Appoints Dr. Thomas Broudy as CEO CDMO Drug Development Biopharmaceutical BioCina Dr. Thomas Broudy
BRIEF published on 10/28/2025 at 08:10, 5 months 17 days ago BioCina nomme le Dr Thomas Broudy au poste de PDG CDMO Biopharmaceutique Développement De Médicaments BioCina Dr Thomas Broudy
PRESS RELEASE published on 10/28/2025 at 08:05, 5 months 17 days ago BioCina Announces Appointment of Dr. Thomas Broudy as Chief Executive Officer BioCina appoints Dr. Thomas Broudy as CEO, bringing 20 years of experience in biopharmaceutical industry. The company aims to grow biologic drug substance and sterile drug product services CEO Appointment BioCina Dr. Thomas Broudy Biologic Drug Substance Sterile Drug Product
Published on 04/14/2026 at 09:05, 1 hour 54 minutes ago BioNxt Initiates GMP Manufacturing of Clinical-Grade Sublingual Cladribine Film Targeting Multiple Sclerosis (MS)
Published on 04/14/2026 at 09:01, 1 hour 58 minutes ago Star Copper Fully Funded 15,000 Metre Drill Program Targets Maiden Resource in 2026
Published on 04/13/2026 at 23:15, 11 hours 44 minutes ago Relevant Gold Completes Strategic Financing; Embarks on Largest Drilling Program in Company History
Published on 04/13/2026 at 23:00, 11 hours 59 minutes ago Sterling Metals Announces Sale Of Sail Pond Project
Published on 04/13/2026 at 22:25, 12 hours 34 minutes ago Findev Inc. Announces Dividend Updates Ex-Dividend Date
Published on 04/14/2026 at 10:30, 28 minutes ago Baucor Boosts European Operations with Strategic Product Expansion
Published on 04/14/2026 at 10:00, 59 minutes ago ARTCLINE achieves milestone in septic shock: Patient recruitment for the ReActIF-ICE study successfully completed
Published on 04/14/2026 at 10:00, 59 minutes ago Waton Financial Marks One Year as a Listed Company with MOTA: A New Chapter in Human-AI Investment Collaboration
Published on 04/14/2026 at 09:57, 1 hour 2 minutes ago Eckert & Ziegler: Metzler Initiates Coverage with a Buy Rating and a Price Target of € 21.00. Upside Potential: 41%
Published on 04/14/2026 at 09:43, 1 hour 16 minutes ago GFT named Leader in QKS Spark Matrix™ 2026 for Insurance Digital Transformation Services, Driving Faster, Lower-Risk Transformation
Published on 04/14/2026 at 08:30, 2 hours 29 minutes ago ALPOU - Groupe POULAILLON - Projet offre publique d'achat obligatoire
Published on 04/13/2026 at 19:14, 15 hours 44 minutes ago ALTAREA - Déclaration d’opérations sur actions propres
Published on 04/13/2026 at 18:15, 16 hours 44 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2026
Published on 04/13/2026 at 18:15, 16 hours 44 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2026
Published on 04/13/2026 at 18:09, 16 hours 49 minutes ago Infotel : Cessation et mise en œuvre d’un nouveau contrat de liquidité avec Invest Securities.
